Antithrombin Budapest 3 An antithrombin variant with reduced heparin affinity resulting from the substitution L99F

The molecular basis and functional properties of a variant antithrombin (AT) protein. AT Budapest 3, were studied. A single base substitution was identified in codon 99, C TC→ T TC, altering the normal leucine to phenylalanine. The proband presented with a history of venous thrombotic disease and wa...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:FEBS letters 1992-04, Vol.300 (3), p.241-246
Hauptverfasser: Olds, R.J., Lane, D.A., Boisclair, M., Sas, G., Bock, S.C., Thein, S.L.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 246
container_issue 3
container_start_page 241
container_title FEBS letters
container_volume 300
creator Olds, R.J.
Lane, D.A.
Boisclair, M.
Sas, G.
Bock, S.C.
Thein, S.L.
description The molecular basis and functional properties of a variant antithrombin (AT) protein. AT Budapest 3, were studied. A single base substitution was identified in codon 99, C TC→ T TC, altering the normal leucine to phenylalanine. The proband presented with a history of venous thrombotic disease and was found to be homozygous for the mutation. The variant protein demonstrated reduced heparin affinity and reduced antiproteinase activity in the presence of either unfractionated heparin or the AT-binding heparin pentasaccharide, when compared to normal AT. A small change in the isoelectric point was also identified. The substituted amino acid residue of AT Budapest 3 is located near to the proposed AT heparin binding site, and it is suggested that reduced heparin affinity of the variant protein may result from substitution-induced distortion of positive charge geometry in the binding site and/or changes in its position relative to the rest of the inhibitor molecule.
doi_str_mv 10.1016/0014-5793(92)80854-A
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_72859516</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>001457939280854A</els_id><sourcerecordid>16235275</sourcerecordid><originalsourceid>FETCH-LOGICAL-c497A-477bd7a618e442307cd6b44d52ed77750c538ea7d76b5aebb36fcb05de87bec63</originalsourceid><addsrcrecordid>eNqNUU1v1DAUtBCoLIV_AJJPqBwC_ozjC1JadVuklbjA2fLHC2uUTRY7abX_HqepgBNwsjwzb549g9BrSt5TQusPhFBRSaX5hWbvGtJIUbVP0IY2ildc1M1TtPkleY5e5PydlHtD9Rk6o1LKWpINSu0wxWmfxoOLA76cgz1CnjDH7YDtn9SdTbEA-L5AOEGYPQS8h2OBi7Lr4hCnUyHy3E9x-Ia7MoenPeA8u1x85imOA95pvX2JnnW2z_Dq8TxHX7fXX65uq93nm09X7a7yQqu2Ekq5oGxNGxCCcaJ8qJ0QQTIISilJvOQNWBVU7aQF53jdeUdkgEY58DU_R29X32Maf8zlV-YQs4e-twOMczaKNVJL-m8hrRmXTMkiFKvQpzHnBJ05pniw6WQoMUsnZgncLIEbzcxDJ6YtY28e_Wd3gPB7aC2h8NuVv489nP7L02yvL9lCLLhmD-iy6ONqBCXWuwjJZB9hKE3FBH4yYYx_f-lPHO2wVw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>16235275</pqid></control><display><type>article</type><title>Antithrombin Budapest 3 An antithrombin variant with reduced heparin affinity resulting from the substitution L99F</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><source>EZB-FREE-00999 freely available EZB journals</source><source>Alma/SFX Local Collection</source><creator>Olds, R.J. ; Lane, D.A. ; Boisclair, M. ; Sas, G. ; Bock, S.C. ; Thein, S.L.</creator><creatorcontrib>Olds, R.J. ; Lane, D.A. ; Boisclair, M. ; Sas, G. ; Bock, S.C. ; Thein, S.L.</creatorcontrib><description>The molecular basis and functional properties of a variant antithrombin (AT) protein. AT Budapest 3, were studied. A single base substitution was identified in codon 99, C TC→ T TC, altering the normal leucine to phenylalanine. The proband presented with a history of venous thrombotic disease and was found to be homozygous for the mutation. The variant protein demonstrated reduced heparin affinity and reduced antiproteinase activity in the presence of either unfractionated heparin or the AT-binding heparin pentasaccharide, when compared to normal AT. A small change in the isoelectric point was also identified. The substituted amino acid residue of AT Budapest 3 is located near to the proposed AT heparin binding site, and it is suggested that reduced heparin affinity of the variant protein may result from substitution-induced distortion of positive charge geometry in the binding site and/or changes in its position relative to the rest of the inhibitor molecule.</description><identifier>ISSN: 0014-5793</identifier><identifier>EISSN: 1873-3468</identifier><identifier>DOI: 10.1016/0014-5793(92)80854-A</identifier><identifier>PMID: 1555650</identifier><language>eng</language><publisher>England: Elsevier B.V</publisher><subject>Amino Acid Sequence ; Antithrombin ; Antithrombin III - chemistry ; Antithrombin III - genetics ; Antithrombin III - isolation &amp; purification ; Base Sequence ; binding ; Carrier Proteins - genetics ; effects on ; Female ; Genetic Variation ; heparin ; Heparin - genetics ; Heparin binding ; Hereditary thrombosis ; Homozygous mutation ; Humans ; identification ; Leucine - genetics ; Molecular Sequence Data ; Mutation ; Phenylalanine - genetics ; variants</subject><ispartof>FEBS letters, 1992-04, Vol.300 (3), p.241-246</ispartof><rights>1992</rights><rights>FEBS Letters 300 (1992) 1873-3468 © 2015 Federation of European Biochemical Societies</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c497A-477bd7a618e442307cd6b44d52ed77750c538ea7d76b5aebb36fcb05de87bec63</citedby><cites>FETCH-LOGICAL-c497A-477bd7a618e442307cd6b44d52ed77750c538ea7d76b5aebb36fcb05de87bec63</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/001457939280854A$$EHTML$$P50$$Gelsevier$$Hfree_for_read</linktohtml><link.rule.ids>314,776,780,3537,27901,27902,65306</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/1555650$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Olds, R.J.</creatorcontrib><creatorcontrib>Lane, D.A.</creatorcontrib><creatorcontrib>Boisclair, M.</creatorcontrib><creatorcontrib>Sas, G.</creatorcontrib><creatorcontrib>Bock, S.C.</creatorcontrib><creatorcontrib>Thein, S.L.</creatorcontrib><title>Antithrombin Budapest 3 An antithrombin variant with reduced heparin affinity resulting from the substitution L99F</title><title>FEBS letters</title><addtitle>FEBS Lett</addtitle><description>The molecular basis and functional properties of a variant antithrombin (AT) protein. AT Budapest 3, were studied. A single base substitution was identified in codon 99, C TC→ T TC, altering the normal leucine to phenylalanine. The proband presented with a history of venous thrombotic disease and was found to be homozygous for the mutation. The variant protein demonstrated reduced heparin affinity and reduced antiproteinase activity in the presence of either unfractionated heparin or the AT-binding heparin pentasaccharide, when compared to normal AT. A small change in the isoelectric point was also identified. The substituted amino acid residue of AT Budapest 3 is located near to the proposed AT heparin binding site, and it is suggested that reduced heparin affinity of the variant protein may result from substitution-induced distortion of positive charge geometry in the binding site and/or changes in its position relative to the rest of the inhibitor molecule.</description><subject>Amino Acid Sequence</subject><subject>Antithrombin</subject><subject>Antithrombin III - chemistry</subject><subject>Antithrombin III - genetics</subject><subject>Antithrombin III - isolation &amp; purification</subject><subject>Base Sequence</subject><subject>binding</subject><subject>Carrier Proteins - genetics</subject><subject>effects on</subject><subject>Female</subject><subject>Genetic Variation</subject><subject>heparin</subject><subject>Heparin - genetics</subject><subject>Heparin binding</subject><subject>Hereditary thrombosis</subject><subject>Homozygous mutation</subject><subject>Humans</subject><subject>identification</subject><subject>Leucine - genetics</subject><subject>Molecular Sequence Data</subject><subject>Mutation</subject><subject>Phenylalanine - genetics</subject><subject>variants</subject><issn>0014-5793</issn><issn>1873-3468</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1992</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqNUU1v1DAUtBCoLIV_AJJPqBwC_ozjC1JadVuklbjA2fLHC2uUTRY7abX_HqepgBNwsjwzb549g9BrSt5TQusPhFBRSaX5hWbvGtJIUbVP0IY2ildc1M1TtPkleY5e5PydlHtD9Rk6o1LKWpINSu0wxWmfxoOLA76cgz1CnjDH7YDtn9SdTbEA-L5AOEGYPQS8h2OBi7Lr4hCnUyHy3E9x-Ia7MoenPeA8u1x85imOA95pvX2JnnW2z_Dq8TxHX7fXX65uq93nm09X7a7yQqu2Ekq5oGxNGxCCcaJ8qJ0QQTIISilJvOQNWBVU7aQF53jdeUdkgEY58DU_R29X32Maf8zlV-YQs4e-twOMczaKNVJL-m8hrRmXTMkiFKvQpzHnBJ05pniw6WQoMUsnZgncLIEbzcxDJ6YtY28e_Wd3gPB7aC2h8NuVv489nP7L02yvL9lCLLhmD-iy6ONqBCXWuwjJZB9hKE3FBH4yYYx_f-lPHO2wVw</recordid><startdate>19920406</startdate><enddate>19920406</enddate><creator>Olds, R.J.</creator><creator>Lane, D.A.</creator><creator>Boisclair, M.</creator><creator>Sas, G.</creator><creator>Bock, S.C.</creator><creator>Thein, S.L.</creator><general>Elsevier B.V</general><scope>6I.</scope><scope>AAFTH</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QL</scope><scope>8FD</scope><scope>C1K</scope><scope>FR3</scope><scope>M81</scope><scope>P64</scope><scope>7X8</scope></search><sort><creationdate>19920406</creationdate><title>Antithrombin Budapest 3 An antithrombin variant with reduced heparin affinity resulting from the substitution L99F</title><author>Olds, R.J. ; Lane, D.A. ; Boisclair, M. ; Sas, G. ; Bock, S.C. ; Thein, S.L.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c497A-477bd7a618e442307cd6b44d52ed77750c538ea7d76b5aebb36fcb05de87bec63</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1992</creationdate><topic>Amino Acid Sequence</topic><topic>Antithrombin</topic><topic>Antithrombin III - chemistry</topic><topic>Antithrombin III - genetics</topic><topic>Antithrombin III - isolation &amp; purification</topic><topic>Base Sequence</topic><topic>binding</topic><topic>Carrier Proteins - genetics</topic><topic>effects on</topic><topic>Female</topic><topic>Genetic Variation</topic><topic>heparin</topic><topic>Heparin - genetics</topic><topic>Heparin binding</topic><topic>Hereditary thrombosis</topic><topic>Homozygous mutation</topic><topic>Humans</topic><topic>identification</topic><topic>Leucine - genetics</topic><topic>Molecular Sequence Data</topic><topic>Mutation</topic><topic>Phenylalanine - genetics</topic><topic>variants</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Olds, R.J.</creatorcontrib><creatorcontrib>Lane, D.A.</creatorcontrib><creatorcontrib>Boisclair, M.</creatorcontrib><creatorcontrib>Sas, G.</creatorcontrib><creatorcontrib>Bock, S.C.</creatorcontrib><creatorcontrib>Thein, S.L.</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Technology Research Database</collection><collection>Environmental Sciences and Pollution Management</collection><collection>Engineering Research Database</collection><collection>Biochemistry Abstracts 3</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>FEBS letters</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Olds, R.J.</au><au>Lane, D.A.</au><au>Boisclair, M.</au><au>Sas, G.</au><au>Bock, S.C.</au><au>Thein, S.L.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Antithrombin Budapest 3 An antithrombin variant with reduced heparin affinity resulting from the substitution L99F</atitle><jtitle>FEBS letters</jtitle><addtitle>FEBS Lett</addtitle><date>1992-04-06</date><risdate>1992</risdate><volume>300</volume><issue>3</issue><spage>241</spage><epage>246</epage><pages>241-246</pages><issn>0014-5793</issn><eissn>1873-3468</eissn><abstract>The molecular basis and functional properties of a variant antithrombin (AT) protein. AT Budapest 3, were studied. A single base substitution was identified in codon 99, C TC→ T TC, altering the normal leucine to phenylalanine. The proband presented with a history of venous thrombotic disease and was found to be homozygous for the mutation. The variant protein demonstrated reduced heparin affinity and reduced antiproteinase activity in the presence of either unfractionated heparin or the AT-binding heparin pentasaccharide, when compared to normal AT. A small change in the isoelectric point was also identified. The substituted amino acid residue of AT Budapest 3 is located near to the proposed AT heparin binding site, and it is suggested that reduced heparin affinity of the variant protein may result from substitution-induced distortion of positive charge geometry in the binding site and/or changes in its position relative to the rest of the inhibitor molecule.</abstract><cop>England</cop><pub>Elsevier B.V</pub><pmid>1555650</pmid><doi>10.1016/0014-5793(92)80854-A</doi><tpages>6</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0014-5793
ispartof FEBS letters, 1992-04, Vol.300 (3), p.241-246
issn 0014-5793
1873-3468
language eng
recordid cdi_proquest_miscellaneous_72859516
source MEDLINE; Elsevier ScienceDirect Journals; EZB-FREE-00999 freely available EZB journals; Alma/SFX Local Collection
subjects Amino Acid Sequence
Antithrombin
Antithrombin III - chemistry
Antithrombin III - genetics
Antithrombin III - isolation & purification
Base Sequence
binding
Carrier Proteins - genetics
effects on
Female
Genetic Variation
heparin
Heparin - genetics
Heparin binding
Hereditary thrombosis
Homozygous mutation
Humans
identification
Leucine - genetics
Molecular Sequence Data
Mutation
Phenylalanine - genetics
variants
title Antithrombin Budapest 3 An antithrombin variant with reduced heparin affinity resulting from the substitution L99F
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-08T11%3A32%3A15IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Antithrombin%20Budapest%203%20An%20antithrombin%20variant%20with%20reduced%20heparin%20affinity%20resulting%20from%20the%20substitution%20L99F&rft.jtitle=FEBS%20letters&rft.au=Olds,%20R.J.&rft.date=1992-04-06&rft.volume=300&rft.issue=3&rft.spage=241&rft.epage=246&rft.pages=241-246&rft.issn=0014-5793&rft.eissn=1873-3468&rft_id=info:doi/10.1016/0014-5793(92)80854-A&rft_dat=%3Cproquest_cross%3E16235275%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=16235275&rft_id=info:pmid/1555650&rft_els_id=001457939280854A&rfr_iscdi=true